Guggenheim Downgrades Incyte (INCY) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| Incyte Genomics, Inc. (NASDAQ: INCY) | Delayed: 122.85 +5.26 (4.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $117.59 | 52 Week High | $118.49 | |||
| Open | $117.52 | 52 Week Low | $55.00 | |||
| Day High | $123.33 | P/E | N/A | |||
| Day Low | $117.52 | EPS | $-0.56 | |||
| Volume | 2,066,536 | |||||
